Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Activated Recombinant Human Factor VII Following Cardiac Bypass Surgery for Paediatric Congenital Heart Disease

This study has been completed.
Sponsor:
Information provided by:
Novo Nordisk A/S
ClinicalTrials.gov Identifier:
NCT01562574
First received: March 22, 2012
Last updated: NA
Last verified: March 2012
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2004
  Primary Completion Date: August 2004 (Final data collection date for primary outcome measure)